Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1995 June; 88(6): 339P–341P.
PMCID: PMC1295241

Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (549K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985 Apr;92(4):385–393. [PubMed]
  • Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod. 1993 Jun;8(6):959–964. [PubMed]
  • Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet. 1990 Nov 10;336(8724):1141–1144. [PubMed]
  • Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 1976 May;57(5):1320–1329. [PMC free article] [PubMed]
  • Burger CW, Korsen T, van Kessel H, van Dop PA, Caron FJ, Schoemaker J. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab. 1985 Dec;61(6):1126–1132. [PubMed]
  • Baird DT, Corker CS, Davidson DW, Hunter WM, Michie EA, Van Look PF. Pituitary-ovarian relationships in polycystic ovary syndrome. J Clin Endocrinol Metab. 1977 Oct;45(4):798–801. [PubMed]
  • Kazer RR, Kessel B, Yen SS. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1987 Aug;65(2):233–236. [PubMed]
  • Venturoli S, Porcu E, Fabbri R, Magrini O, Gammi L, Paradisi R, Forcacci M, Bolzani R, Flamigni C. Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome. Clin Endocrinol (Oxf) 1988 Jan;28(1):93–107. [PubMed]
  • Murdoch AP, Diggle PJ, White MC, Kendall-Taylor P, Dunlop W. LH in polycystic ovary syndrome: reproducibility and pulsatile secretion. J Endocrinol. 1989 Apr;121(1):185–191. [PubMed]
  • Rossmanith WG, Keckstein J, Spatzier K, Lauritzen C. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease. Clin Endocrinol (Oxf) 1991 Mar;34(3):223–230. [PubMed]
  • Gadir AA, Khatim MS, Mowafi RS, Alnaser HM, Alzaid HG, Shaw RW. Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization. Clin Endocrinol (Oxf) 1990 Jun;32(6):749–754. [PubMed]
  • Adashi EY, Hsueh AJ, Yen SS. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 1981 Apr;108(4):1441–1449. [PubMed]
  • Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989 Apr;30(4):459–470. [PubMed]
  • Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab. 1989 Jul;69(1):151–157. [PubMed]
  • Wang CF, Lasley BL, Lein A, Yen SS. The functional changes of the pituitary gonadotrophs during the menstrual cycle. J Clin Endocrinol Metab. 1976 Apr;42(4):718–728. [PubMed]
  • Chang RJ, Mandel FP, Lu JK, Judd HL. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J Clin Endocrinol Metab. 1982 Mar;54(3):490–494. [PubMed]
  • Buckler HM, McLachlan RI, MacLachlan VB, Healy DL, Burger HG. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration. J Clin Endocrinol Metab. 1988 Apr;66(4):798–803. [PubMed]
  • Sopelak VM, Hodgen GD. Blockade of the estrogen-induced luteinizing hormone surge in monkeys: a nonsteroidal, antigenic factor in porcine follicular fluid. Fertil Steril. 1984 Jan;41(1):108–113. [PubMed]
  • Messinis IE, Templeton A, Baird DT. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. J Clin Endocrinol Metab. 1985 Dec;61(6):1076–1080. [PubMed]
  • Balen AH, Jacobs HS. Gonadotrophin surge attenuating factor: a missing link in the control of LH secretion? Clin Endocrinol (Oxf) 1991 Nov;35(5):399–402. [PubMed]
  • Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries--a common finding in normal women. Lancet. 1988 Apr 16;1(8590):870–872. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press